Search

Search articles for

Advanced filters

Published AfterYearMonthDay

Published BeforeYearMonthDay

By Author

By Section

By Issue

Search Results

##search.searchResults.foundPlural##

Ustekinumab in the treatment of acute disseminated pyoderma gangrenosum in a patient with Crohn’s disease

Klaudia Miklusiak, Karol Miklusiak, Olga Kaczmarczyk, Dorota Cibor, Małgorzata Zwolińska-Wcisło

22-05-2023

https://doi.org/10.4081/dr.2023.9630

1107

PDF: 587

HTML: 89
Late reaction to ustekinumab infusion

Marina Resener Morais, Luana Pizarro Meneghello, Carina Flores de Oliveira, André Vicente Esteves Carvalho

e2

09-09-2013

https://doi.org/10.4081/dr.2013.e2

3988

PDF: 691

HTML: 268
Psoriasis, biological drugs and Coronavirus Disease 2019: Real life experience of two Italian provinces

Martina Vispi, Teresa Corradin, Camilla Peccianti, Luca Feci, Laura Casini, Chiara Pisani, Susanna Fabbroni, Paola Corsetti, Margherita Croatto, Michele Pellegrino

25-06-2020

https://doi.org/10.4081/dr.2020.8642

1395

PDF: 769

HTML: 16
Atopic dermatitis: a brief review of recent advances in its management

Sultan Daghafak Alenazi

23-05-2023

https://doi.org/10.4081/dr.2023.9678

2491

PDF: 1443

HTML: 122
Seven cancer patients receiving guselkumab for treatment of moderate-to-severe psoriasis

Luca Mastorino, Niccolò Siliquini, Gianluca Avallone, Michela Ortoncelli, Pietro Quaglino, Paolo Dapavo, Simone Ribero

17-03-2022

https://doi.org/10.4081/dr.2022.9282

1195

PDF: 855

HTML: 47
Dermatological insight as the key to diagnosing intestinal Behçet’s disease misdiagnosed as Crohn’s: a case report

Caterina Mariarosaria Giorgio, Eugenia Veronica Di Brizzi, Gaetano Licata, Carmine Fiorentino, Giuseppe Argenziano, Luca Damiani

04-02-2025

https://doi.org/10.4081/dr.2025.10232

548

PDF: 356

HTML: 23
Erythrodermic psoriasis treated with apremilast

John Arcilla, Daniel Joe, Johnathan Kim, Yohanan Kim, VuAnh N. Truong, Navin Jaipaul

19-09-2016

https://doi.org/10.4081/dr.2016.6599

2186

PDF: 988

HTML: 607
Tildrakizumab in the treatment of plaque psoriasis in an HIV+ patient: a case report and literature review of anti-interleukin drugs

Viviana Lora, Dario Graceffa, Monia Di Prete, Carlo Cota

11-11-2024

https://doi.org/10.4081/dr.2024.10140

1068

PDF: 568

SUPPLEMENTARY MATERIAL: 182

HTML: 21
Exacerbation of generalized plaque psoriasis after tuberculin test

Alberto Corrà, Lavinia Quintarelli, Alice Verdelli, Walter Volpi, Marzia Caproni

28-07-2021

https://doi.org/10.4081/dr.2021.9019

3202

PDF: 525

HTML: 284
Certolizumab to treat hidradenitis suppurativa

Asem Shadid, Saud Alobaida, Yousef Binamer

27-10-2022

https://doi.org/10.4081/dr.2022.9566

1972

PDF: 751

HTML: 43
Maculopapular sarcoidosis: the importance of skin signs

Giovanna Galdo, Gelsomina Luongo, Daniela Capacchione, Damiano Abeni, Marta Grimaldi, Luca Fania

16-09-2022

https://doi.org/10.4081/dr.2022.9561

1046

PDF: 398

HTML: 38
Efficacy and safety of risankizumab in patients with erythrodermic and sub-erythrodermic psoriasis: a case series

Andrea D'Arino, Maria Concetta Fargnoli, Pasquale Frascione, Chiara Assorgi, Annunziata Dattola, Viviana Lora, Matteo Megna, Flavia Pigliacelli, Emanuele Vagnozzi, Diego Orsini

30-07-2025

https://doi.org/10.4081/dr.2025.10379

542

PDF: 373

HTML: 9
Adalimumab-induced facial erysipelas and its successful resolution with azithromycin in a 19-year-old female

Caterina Mariarosaria Giorgio, Anna Balato, Gaetano Licata, Giuseppe Argenziano, Vittorio Tancredi, Eugenia Veronica Di Brizzi

21-02-2025

https://doi.org/10.4081/dr.2025.10278

489

PDF: 323

HTML: 21
Herpes vegetans, an atypical herpes lesion in HIV patient: A case report

Sondang P. Sirait, Wresti Indriatmi

14-03-2022

https://doi.org/10.4081/dr.2022.9180

2705

PDF: 893

HTML: 22
Biologics and small molecules treatment for moderate-to-severe atopic dermatitis patients with comorbid conditions and special populations: an Italian perspective

Alba Guglielmo, Maria Ludovica Deotto , Luigi Naldi , Giuseppe Stinco, Alessandro Pileri, Bianca Maria Piraccini, Anna Belloni Fortina, Andrea Sechi

13-09-2023

https://doi.org/10.4081/dr.2023.9839

2834

PDF: 1007

HTML: 37
A cohort study of obese patients with moderate-to-severe psoriasis using biological medicines in Catalonia, Spain

Judit Riera-Arnau, Daniel Wang, Jordi Mollet, Lucía Bellas, Ricardo Boy, Carlos González-Cruz, Mònica Sabaté, Elena Ballarín, Vicenç García-Patos, Glòria Aparicio

23-06-2026

https://doi.org/10.4081/dr.2026.10247

843

PDF: 282

SUPPLEMENTARY MATERIAL: 27
A severe psoriasis flare after COVID-19 treated with risankizumab: complete skin clearance after 16 weeks

Luciano Ibba, Luigi Gargiulo, Giulia Pavia, Alessandra Narcisi, Antonio Costanzo, Mario Valenti

06-06-2023

https://doi.org/10.4081/dr.2023.9722

835

PDF: 480

HTML: 25
Long term efficacy, safety, and tolerability of tildrakizumab in epileptic patient with psoriasis and eczema

Nicoletta Bernardini, Nevena Skroza, Giovanni Rossi, Alessandra Mambrin, Ersilia Tolino, Federica Marraffa, Martina Caviglia, Antonio Di Guardo, Salvatore Volpe, Ilaria Proietti, Concetta Potenza

21-11-2022

https://doi.org/10.4081/dr.2022.9447

1415

PDF: 425

HTML: 48
Pityriasis following COVID-19 vaccinations: a systematic review

Laura Duzett, Guadalupe Mercado, Vasiliki Tasouli-Drakou, Alicia Kane, Alison Tam

09-08-2023

https://doi.org/10.4081/dr.2023.9742

1372

PDF: 771

Supplementary Material: 154

HTML: 85
Efficacy of adalimumab in moderate to severe hidradenitis suppurativa: Real life data

Aikaterini Kyriakou, Anastasia Trigoni, Nikiforos Galanis, Dimitrios Sotiriadis, Aikaterini Patsatsi

01-10-2018

https://doi.org/10.4081/dr.2018.7859

2066

PDF: 1086

HTML: 81
Anti-interleukin-17 and anti-interleukin-23 biologic drugs for genital psoriasis: a single-center retrospective comparative study

Andrea Cortese, Luigi Gargiulo, Luciano Ibba, Giovanni Fiorillo, Francesco Toso, Carlo Alberto Vignoli, Alessandra Narcisi, Antonio Costanzo, Mario Valenti

19-05-2023

https://doi.org/10.4081/dr.2023.9692

1147

PDF: 570

HTML: 25
Lentiginous eruption in resolving psoriasis plaques during treatment with ixekizumab: a case report and review of the literature

Pablo Santa María, Fernando Valenzuela, Claudia Morales, Raul De la Fuente, Roberto Cullen

11-10-2017

https://doi.org/10.4081/dr.2017.7079

1424

PDF: 682

HTML: 146
Dimethyl fumarate as a safe and effective therapy for recalcitrant psoriasis in comorbid patients

Martina Burlando, Mattia Fabio Molle, Emanuele Cozzani, Aurora Parodi

14-03-2022

https://doi.org/10.4081/dr.2022.9091

2656

PDF: 651

HTML: 12

1 - 23 of 23 items

Search

Search Results

Ustekinumab in the treatment of acute disseminated pyoderma gangrenosum in a patient with Crohn’s disease

Late reaction to ustekinumab infusion

Psoriasis, biological drugs and Coronavirus Disease 2019: Real life experience of two Italian provinces

Atopic dermatitis: a brief review of recent advances in its management

Seven cancer patients receiving guselkumab for treatment of moderate-to-severe psoriasis

Dermatological insight as the key to diagnosing intestinal Behçet’s disease misdiagnosed as Crohn’s: a case report

Erythrodermic psoriasis treated with apremilast

Tildrakizumab in the treatment of plaque psoriasis in an HIV+ patient: a case report and literature review of anti-interleukin drugs

Exacerbation of generalized plaque psoriasis after tuberculin test

Certolizumab to treat hidradenitis suppurativa

Maculopapular sarcoidosis: the importance of skin signs

Efficacy and safety of risankizumab in patients with erythrodermic and sub-erythrodermic psoriasis: a case series

Adalimumab-induced facial erysipelas and its successful resolution with azithromycin in a 19-year-old female

Herpes vegetans, an atypical herpes lesion in HIV patient: A case report

Biologics and small molecules treatment for moderate-to-severe atopic dermatitis patients with comorbid conditions and special populations: an Italian perspective

A cohort study of obese patients with moderate-to-severe psoriasis using biological medicines in Catalonia, Spain

A severe psoriasis flare after COVID-19 treated with risankizumab: complete skin clearance after 16 weeks

Long term efficacy, safety, and tolerability of tildrakizumab in epileptic patient with psoriasis and eczema

Pityriasis following COVID-19 vaccinations: a systematic review

Efficacy of adalimumab in moderate to severe hidradenitis suppurativa: Real life data

Anti-interleukin-17 and anti-interleukin-23 biologic drugs for genital psoriasis: a single-center retrospective comparative study

Lentiginous eruption in resolving psoriasis plaques during treatment with ixekizumab: a case report and review of the literature

Dimethyl fumarate as a safe and effective therapy for recalcitrant psoriasis in comorbid patients

authors

reviewers

Categories

indexing

dermatopathology